Health
FDA approves marketing of first AI-based device to assist clinicians during colon cancer screening – News-Medical.net
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning…
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with traditional screenings or surveillance methods, it…
-
General23 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News24 hours agoPolice appeal for information after two men found dead
-
General23 hours agoTariff letters to 12 countries going out Monday: Trump
-
General24 hours agoCan the world be governed without the US? • Inside Story